Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) FCF Margin (2020 - 2025)

Historic FCF Margin for Pulse Biosciences (PLSE) over the last 4 years, with Q3 2025 value amounting to 15233.72%.

  • Pulse Biosciences' FCF Margin changed N/A to 15233.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 56713.95%, marking a year-over-year change of. This contributed to the annual value of 6773.43% for FY2022, which is 29275900.0% down from last year.
  • Per Pulse Biosciences' latest filing, its FCF Margin stood at 15233.72% for Q3 2025.
  • Over the past 5 years, Pulse Biosciences' FCF Margin peaked at 88955.56% during Q4 2022, and registered a low of 15233.72% during Q3 2025.
  • In the last 3 years, Pulse Biosciences' FCF Margin had a median value of 1936.52% in 2021 and averaged 9434.24%.
  • Its FCF Margin has fluctuated over the past 5 years, first soared by 1573800900bps in 2021, then crashed by -138714900bps in 2022.
  • Quarter analysis of 3 years shows Pulse Biosciences' FCF Margin stood at 1519.91% in 2021, then skyrocketed by 5953bps to 88955.56% in 2022, then tumbled by -117bps to 15233.72% in 2025.
  • Its FCF Margin stands at 15233.72% for Q3 2025, versus 88955.56% for Q4 2022 and 4280.33% for Q2 2022.